|
1
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends - an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Taitt HE: Global Trends and prostate
cancer: A Review of incidence, detection, and mortality as
influenced by race, ethnicity, and geographic location. Am J Men
Health. 12:1807–1823. 2018. View Article : Google Scholar
|
|
3
|
Curado MP, Oliveira MM, Silva DRM and
Souza DLB: Epidemiology of multiple myeloma in 17 Latin American
countries: An update. Cancer Med. 7:2101–2108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boloker G, Wang C and Zhang J: Updated
statistics of lung and bronchus cancer in United States (2018). J
Thorac Dis. 10:1158–1161. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leithner D, Horvat JV, Ochoa-Albiztegui
RE, Thakur S, Wengert G, Morris EA, Helbich TH and Pinker K:
Imaging and the completion of the omics paradigm in breast cancer.
Radiologe. 58 (Suppl 1):7–13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suppan C and Balic M: Early stage breast
cancer treatment and prognostic factors: Post San Antonio Breast
Cancer Symposium 2016. Memo. 10:82–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG), : Effects of chemotherapy and
hormonal therapy for early breast cancer on recurrence and 15-year
survival: An overview of the randomised trials. Lancet.
365:1687–1717. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Feng Y, Spezia M, Huang S, Yuan C, Zeng Z,
Zhang L, Ji X, Liu W, Huang B, Luo W, et al: Breast cancer
development and progression: Risk factors, cancer stem cells,
signaling pathways, genomics, and molecular pathogenesis. Genes
Dis. 5:77–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang XM, Zhang Z, Pan LH, Cao XC and Xiao
C: KRT19 and CEACAM5 mRNA-marked circulated tumor cells indicate
unfavorable prognosis of breast cancer patients. Breast Cancer Res
Treat. 174:375–385. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ramos EAS, Silva CT, Manica GC, Pereira
IT, Klassen LM, Ribeiro EM, Cavalli IJ, Braun-Prado K, Lima RS,
Urban CA, et al: Worse prognosis in breast cancer patients can be
predicted by immunohistochemical analysis of positive MMP-2 and
negative estrogen and progesterone receptors. Rev Assoc Med Bras
(1992). 62:774–781. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao Y, Cao Q, Lu L, Zhang X, Zhang Z, Dong
X, Jia W and Cao Y: Kruppel-like factor family genes are expressed
during Xenopus embryogenesis and involved in germ layer formation
and body axis patterning. Dev Dyn. 244:1328–1346. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kerr K, Qualmann K, Esquenazi Y, Hagan J
and Kim DH: Familial syndromes involving meningiomas provide
mechanistic insight into sporadic disease. Neurosurgery.
83:1107–1118. 2018.PubMed/NCBI
|
|
13
|
Cho N: Molecular subtypes and imaging
phenotypes of breast cancer. Ultrasonography. 35:281–288. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Apara A, Galvao J, Wang Y, Blackmore M,
Trillo A, Iwao K, Brown DP Jr, Fernandes KA, Huang A, Nguyen T, et
al: KLF9 and JNK3 interact to suppress axon regeneration in the
adult CNS. J Neurosci. 37:9632–9644. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yılmaz TU, Trabzonlu L, Güler SA, Baran
MA, Pösteki G, Erçin C and Utkan Z: Characteristics of special type
breast tumors in our center. Eur J Breast Health. 14:17–22. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song JL, Chen C, Yuan JP and Sun SR:
Progress in the clinical detection of heterogeneity in breast
cancer. Cancer Med. 5:3475–3488. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Noguchi K, Eguchi H, Konno M, Kawamoto K,
Nishida N, Koseki J, Wada H, Marubashi S, Nagano H, Doki Y, et al:
Susceptibility of pancreatic cancer stem cells to reprogramming.
Cancer Sci. 106:1182–1187. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ying M, Tilghman J, Wei Y,
Guerrero-Cazares H, Quinones-Hinojosa A, Ji H and Laterra J:
Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through
global transcription repression and integrin α6 inhibition. J Biol
Chem. 289:32742–32756. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fu DZ, Cheng Y, He H, Liu HY and Liu YF:
The fate of Krüppel-like factor 9-positive hepatic carcinoma cells
may be determined by the programmed cell death protein 5. Int J
Oncol. 44:153–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Limame R, de Beeck KO, Van Laere S, Croes
L, De Wilde A, Dirix L, Van Camp G, Peeters M, De Wever O, Lardon
F, et al: Expression profiling of migrated and invaded breast
cancer cells predicts early metastatic relapse and reveals
Krüppel-like factor 9 as a potential suppressor of invasive growth
in breast cancer. Oncoscience. 1:69–81. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Menyhárt O, Fekete JT and Győrffy B:
Demographic shift disproportionately increases cancer burden in an
aging nation: Current and expected incidence and mortality in
Hungary up to 2030. Clin Epidemiol. 10:1093–1108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vangangelt KMH, van Pelt GW, Engels CC,
Putter H, Liefers GJ, Smit VTHBM, Tollenaar RAEM, Kuppen PJK and
Mesker WE: Prognostic value of tumor-stroma ratio combined with the
immune status of tumors in invasive breast carcinoma. Breast Cancer
Res Treat. 168:601–612. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dieci MV, Vernaci G and Guarneri V:
Escalation and de-escalation in HER2 positive early breast cancer.
Curr Opin Oncol. 31:35–42. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang L, Lü B, Xu J, Hu H and Lai M:
Downregulation of Krüppel-like factor 9 in human colorectal cancer.
Pathol Int. 58:334–338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Galvao J, Beach KM, Luo W, Urrutia
RA, Goldberg JL and Otteson DC: Novel roles and mechanism for
Krüppel-like factor 16 (KLF16) regulation of neurite outgrowth and
ephrin receptor A5 (EphA5) expression in retinal ganglion cells. J
Biol Chem. 291:18084–18095. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kang L and Lai MD: BTEB/KLF9 and its
transcriptional regulation. Yi Chuan. 29:515–522. 2007.(In
Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ying M, Sang Y, Li Y, Guerrero-Cazares H,
Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S and Laterra J:
Krüppel-like family of transcription factor 9, a
differentiation-associated transcription factor, suppresses Notch1
signaling and inhibits glioblastoma-initiating stem cells. Stem
Cells. 29:20–31. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bai XY, Li S, Wang M, Li X, Yang Y, Xu Z,
Li B, Li Y, Xia K, Chen H, et al: Krüppel-like factor 9
down-regulates matrix metalloproteinase 9 transcription and
suppresses human breast cancer invasion. Cancer Lett. 412:224–235.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun J, Wang B and Liu Y, Zhang L, Ma A,
Yang Z, Ji Y and Liu Y: Transcription factor KLF9 suppresses the
growth of hepatocellular carcinoma cells in vivo and positively
regulates p53 expression. Cancer Lett. 355:25–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shen P, Sun J, Xu G, Zhang L, Yang Z, Xia
S, Wang Y, Liu Y and Shi G: KLF9, a transcription factor induced in
flutamide-caused cell apoptosis, inhibits AKT activation and
suppresses tumor growth of prostate cancer cells. Prostate.
74:946–958. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hosseini MK, Gunel T, Gumusoglu E, Benian
A and Aydinli K: MicroRNA expression profiling in placenta and
maternal plasma in early pregnancy loss. Mol Med Rep. 17:4941–4952.
2018.PubMed/NCBI
|
|
32
|
Chen Y, Liu X, Li Y, Quan C, Zheng L and
Huang K: Lung cancer therapy targeting histone methylation:
opportunities and challenges. Comput Struct Biotechnol J.
16:211–223. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie VK, Li Z, Yan Y, Jia Z, Zuo X, Ju Z,
Wang J, Du J, Xie D, Xie K, et al: DNA-methyltransferase 1 induces
dedifferentiation of pancreatic cancer cells through silencing of
Krüppel-Like factor 4 expression. Clin Cancer Res. 23:5585–5597.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Blanchette PS, Desautels DN, Pond GR,
Bartlett JMS, Nofech-Mozes S, Yaffe MJ and Pritchard KI: Factors
influencing survival among patients with HER2-positive metastatic
breast cancer treated with trastuzumab. Breast Cancer Res Treat.
170:169–177. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xu T, Li D, He Y, Zhang F, Qiao M and Chen
Y: The expression level of CSDAP1 in lung cancer and its clinical
significance. Oncol Lett. 16:4361–4366. 2018.PubMed/NCBI
|
